Accountable Care Organizations Still Play a Vital Role in Value-Based Care
Moving away from accountable care organizations (ACOs) will not lead to value-based care, according to Luke Hansen, M.D., M.H.S., and chief medical officer of Arcadia, a healthcare data analytics company.
Accountable care organizations (ACOs) still play an important role in value-based care, and shifting away from them at this time would be a mistake, according to Luke Hansen, M.D., M.H.S. In a video interview with Managed Healthcare Executive, Hansen explained why ACOs are still important.
Luke Hansen, M.D., M.H.S.
“Bundled programs are a necessary piece,” Hansen said. “The ACO structure can transfer accountability for cost to PCPs [primary care physicians], but at the end of the day, if you play that out and you really start to tighten the screws, I worry we end up back where we were with managed care 1.0, where the PCPs become gatekeepers.”
Hansen went on to explain that thoughtfully transferring risk to organizations is the key to success.
“If we were to just transfer risk, in a thoughtful way, to an organization to get them to think more about a population attribution than clinic visit volume—that's the key component of the program that's needed,” Hansen continued. “Right now, there are still the engines, the machines, of the provider industry attuned to visits, which are inherently reactive. If we could figure out a way to give accountability for populations to these organizations, they could reverse engineer how to get to those people and bring them in appropriately.”
Increased Risk of Severe RSV Illness in Adults With Asthma or COPD
March 19th 2025Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a significant threat to adults with asthma and COPD. However, research on the virus within these groups has been limited.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Study Finds Adherence to Annual Lung Cancer Screening Linked to Higher Detection Rates
March 18th 2025Researchers found that adherence to the first and second annual screenings was 61% and 51%, respectively, with higher lung cancer detection rates observed in those who followed through on these screenings.
Read More
